How Does the Covıd-19 Pandemıc Affect the Target 90-90-90?

Author(s): Hayat Kumbasar Karaosmanoglu*

Journal Name: Current HIV Research
HIV and Viral Immune Diseases

Volume 19 , Issue 2 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

In 2014, The Joint United Nations Program on HIV and AIDS (UNAIDS) has set an ambitious target code-named 90-90-90, which aims to ensure that 90% of all people living with HIV will know their state, 90% of all people diagnosed will receive sustained antiretroviral therapy, and 90% of all people receiving ART will have viral suppression by 2020. Since 2014, many tests and treatment programs have been developed to achieve the above goals worldwide. In 2019, it was reported that many developed countries can reach the target with the right strategies, as well as regions that are still far from the targets.

It has been reported that the fourth 90 should be one of the targets related to HIV infection in recent years. This view, beyond virological suppression, was towards developing programs that would enable people living with HIV to live not only longer but also healthy.

The socio-cultural and economic obstacles to reach the targets may vary according to geographical regions, but it is clear that COVID-19 disease, which has taken the whole world under the influence since 2019, is a major obstacle to the 90-90-90 targets worldwide.

Difficulties in the diagnosis and access to ART and treatment nonadherence which may be encountered more frequently due to many factors may threaten both the health of people living with HIV and public health.

The COVID-19 pandemic has disrupted many programs developed in the fight against the HIV epidemic.

Considering COVID-19 disease and future epidemics that may create a chaotic environment, analyzing the difficulties experienced in the pandemic retrospectively, and determining new strategies that will bring appropriate solutions to the problems will play an important role in the proper management of future issues.

Keywords: HIV AIDS, COVID-19, pandemic, the target 90-90-90, PLWHIV, ART.

[1]
Joint United National Programme on HIV/AIDS (UNAIDS). 90–90–90: an ambitious treatment target to help end the AIDS epidemic 2014.
[2]
Huerga H, Van Cutsem G, Ben Farhat J, et al. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: A household-based community cross-sectional survey. BMC Public Health 2018; 18(1): 303-1303.
[http://dx.doi.org/10.1186/s12889-018-5208-0] [PMID: 29499668]
[3]
Gaolathe T, Wirth KE, Holme MP, et al. Botswana Combination Prevention Project study team. Botswana’s progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV 2016; 3(5): e221-30.
[http://dx.doi.org/10.1016/S2352-3018(16)00037-0] [PMID: 27126489]
[4]
Porter K, Gourlay A, Attawell K, et al. ECDC dublin declaration monitoring network. substantial heterogeneity in progress toward reaching the 90–90–90 HIV target in the who european region. J Acquir Immune Defic Syndr 2018; 79(1): 28-37.
[http://dx.doi.org/10.1097/QAI.0000000000001761] [PMID: 29847474]
[5]
Kisesa A, Chamla D. Getting to 90-90-90 targets for children and adolescents HIV in low and concentrated epidemics: Bottlenecks, opportunities, and solutions. Curr Opin HIV AIDS 2016; 11(Suppl. 1): S1-5.
[http://dx.doi.org/10.1097/COH.0000000000000264] [PMID: 26945141]
[6]
Doshi RH, Sande E, Ogwal M, et al. Progress toward UNAIDS 90-90-90 targets: A respondent-driven survey among female sex workers in Kampala, Uganda. PLoS One 2018; 13(9): e0201352.
[http://dx.doi.org/10.1371/journal.pone.0201352] [PMID: 30231030]
[7]
Marsh K, Eaton JW, Mahy M, et al. Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target. AIDS 2019; 33(Suppl. 3): S213-26.
[http://dx.doi.org/10.1097/QAD.0000000000002355] [PMID: 31490781]
[8]
Guaraldi G, Arends J, Buhk T, et al. “Moving Fourth”: A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression. AIDS Rev 2019; 21(3): 135-42.
[http://dx.doi.org/10.24875/AIDSRev.19000088] [PMID: 31532396]
[9]
Harris TG, Rabkin M, El-Sadr WM. Achieving the fourth 90: healthy aging for people living with HIV. AIDS 2018; 32(12): 1563-9.
[http://dx.doi.org/10.1097/QAD.0000000000001870] [PMID: 29762172]
[10]
Kall M, Marcellin F, Harding R, Lazarus JV, Carrieri P. Patient-reported outcomes to enhance person-centred HIV care. Lancet HIV 2020; 7(1): e59-68.
[http://dx.doi.org/10.1016/S2352-3018(19)30345-5] [PMID: 31776101]
[11]
People living with HIV in Wuhan struggle to find medicine during coronavirus outbreak—CNN. https://www.cnn.com/2020/03/13/health/coronavirus-china-hiv-wuhan-intl-hnk/index.html
[12]
Drug Shortage Concerns Are Top of Mind Amid COVID-19 Outbreak times.com/news/drug-shortage-concerns-are-top-of- mind-amid-covid-19-outbreak
[13]
FDA Coronavirus (COVID-19) supply chain update. [cited 2020 Mar 19]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chain-update
[15]
Prevention Access Campaign. Undetectable=Un transmittable 2018. https://www. preventionaccess.org/undetectable2018.
[16]
Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV 2017. https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/0
[17]
Robert W. Eisinger, Carl W. Dieffenbach, Anthony S. Fauci. HIV Viral Load and Transmissibility of HIV Infection. JAMA 2019; 321: 451-2.
[http://dx.doi.org/10.1001/jama.2018.21167]
[18]
Miners A, Phillips A, Kreif N, et al. ASTRA (Antiretrovirals, Sexual Transmission, and Attitudes) Study. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV 2014; 1: 32-40.
[http://dx.doi.org/10.1016/S2352-3018(14)70018-9]
[19]
Cooper V, Clatworthy J, Harding R, Whetham J. Measuring quality of life among people living with HIV: A systematic review of reviews. Health Qual Life Outcomes 2017; 15(1): 220.
[http://dx.doi.org/10.1186/s12955-017-0778-6] [PMID: 29141645]
[20]
Ghiasvand H, Waye KM, Noroozi M, Harouni GG, Armoon B, Bayani A. Clinical determinants associated with quality of life for people who live with HIV/AIDS: a Meta-analysis. BMC Health Serv Res 2019; 19(1): 768.
[http://dx.doi.org/10.1186/s12913-019-4659-z] [PMID: 31665007]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 2
Year: 2021
Published on: 25 November, 2020
Page: [103 - 105]
Pages: 3
DOI: 10.2174/1570162X18999201125212538

Article Metrics

PDF: 26